GLYCOSA team
Pradeep Karla, Ph.D., LEAD
Pradeep Karla, Ph.D., LEAD
Pradeep Karla, Ph.D., LEAD
CEO - Obtained his Ph.D. in Pharmaceutical Sciences from the University of Missouri-Kansas City and completed the one-year professional leadership training (LEAD) from the Stanford University, Graduate School of Business.
Mohammadali Kochakzade
Pradeep Karla, Ph.D., LEAD
Pradeep Karla, Ph.D., LEAD
Master's degree in Medical Engineering at AUT, winner of several awards in this field, and several patents in Bio-Engineering, working experience with large medical companies as an R&D engineering manager.
Dimiter Avtanski, Ph.D.
Dimiter Avtanski, Ph.D.
Dimiter Avtanski, Ph.D.
Director of the Endocrine Research Laboratory at the Gerald J. Friedman Diabetes Institute, Lenox Hill Hospital in New York City, an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and an Investigator at the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical
Director of the Endocrine Research Laboratory at the Gerald J. Friedman Diabetes Institute, Lenox Hill Hospital in New York City, an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and an Investigator at the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research. processing and making meaningful the signals received from human tissue.
Dr. Avtanski is a highly accomplished researcher with numerous publications in prestigious scientific journals and has made significant contributions to the field of obesity, diabetes, and breast cancer progression.
Ehsan Karami
Dimiter Avtanski, Ph.D.
Dimiter Avtanski, Ph.D.
Master's degree in Bio-Electrical Engineering at UT and professional artificial intelligence programmer in the field of medical signals and work and scientific experience in excellent processing and making meaningful the signals received from human tissue.
About GLYCOSA
Our team was founded by a group of creative and entrepreneurial people to improve quality of life and patient care through continuous non-invasive monitoring of blood glucose.
The group has conducted extensive tests and studies in the field since 2019 and has succeeded in designing accurate blood glucose measuring device with an affordable price and high accuracy. We completed extensive clinical trials of our device, and are prepared to launch our brand in the global market .